News

Pfizer raises 2025 EPS guidance to $2.90–$3.10 while targeting margin expansion through $7.7B cost savings by 2027
Pfizer Q2 2025 earnings show 10% revenue growth, raised EPS guidance, strong R&D, and operational execution. Explore growth drivers and policy risks.
Pfizer Inc. (PFE) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Conference Call August 5, 2025 10:00 AM ETCompany ParticipantsAamir Malik - Corporate ParticipantAlbert Bourla ...
DuPont raises adjusted EPS guidance to $4.40 and targets $3.36B operating EBITDA amid Qnity spin-off preparations
The company is advancing its planned spin-off of Qnity Electronics, maintaining a November 1 separation date. Koch highlighted additions to the Qnity Board and shared, "The Qnity Board will be ...
Everybody appearing in civil matters at Sydney District Court, Wednesday, August 6
Here is a list of civil matters listed at Sydney District Court on Wednesday. Today's court listings are published as part of ...
Everybody appearing at Waverley Local Court, Wednesday, August 6
Here is a list of matters listed at Waverley Local Court on Wednesday. Today's court listings are published as part of News Corporation's commitment to public interest journalism and are compiled from ...